LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 29, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR AVANTOR INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

image for news Deadline Alert: Avantor, Inc. (AVTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).

image for news Deadline Alert: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Google unveils "Nano Banana Pro" AI Image generator — Positive

GOOG  GOOGL   CNBC Television — November 20, 2025

CNBC's Deirdre Bosa reports on news regarding Alphabet.

image for news Google unveils "Nano Banana Pro" AI Image generator

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX) securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”).

image for news Deadline Alert: Marex Group PLC (MRX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Carson Block says it's not time to short Big Tech of Nvidia — Positive

NVDA   Bloomberg Markets and Finance — November 20, 2025

It's not the time to bet against the biggest US technology names, short-seller Carson Block tells Kriti Gupta, even as warnings rise about a potential bubble in artificial intelligence https://www.bloomberg.com/news/articles/2025-11-20/muddy-waters-block-says-it-s-not-the-time-to-short-big-tech

image for news Carson Block says it's not time to short Big Tech of Nvidia

Rising Connectivity Demand Lifts ALAB: Can Its Platform Keep Growing? — Positive

ALAB   Zacks Investment Research — November 20, 2025

Astera Labs rises on soaring hyperscaler demand as its Connectivity Platform powers next-gen AI data centers, but sustaining this momentum poses key challenges.

image for news Rising Connectivity Demand Lifts ALAB: Can Its Platform Keep Growing?

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired WPP plc (“WPP” or the “Company”) (NYSE: WPP) common stock between February 27, 2025 and July 8, 2025, inclusive (the “Class Period”).

image for news Deadline Alert: WPP plc (WPP) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Nayax: Q3 Reinforces The Bull Case — Positive

NYAX   Seeking Alpha — November 20, 2025

Nayax Ltd. remains a Buy as Q3 results confirm strong fundamentals, with robust recurring revenue and improving margins driving long-term growth potential. NYAX's recurring revenue engine, now 73.9% of total revenue, is supported by expansion into higher-ticket verticals like EV charging and amusement. Gross margin expansion and operating leverage are enhancing profitability, supporting management's ambitious 2028 targets for revenue growth and EBITDA margin.

image for news Nayax: Q3 Reinforces The Bull Case

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public.

image for news WAL Investor News: If You Have Suffered Losses in Western Alliance Bancorporation (NYSE: WAL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.

image for news AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Walmart Lifts FY26 Outlook on Q3 Earnings & Revenue Beat — Positive

WMT   Zacks Investment Research — November 20, 2025

WMT lifts its FY26 outlook after Q3 revenues and earnings beat estimates, powered by rapid e-commerce growth and solid segment performance.

image for news Walmart Lifts FY26 Outlook on Q3 Earnings & Revenue Beat

Can Visa Gain More Ground as Cash App Flexes Into Pay-Over-Time? — Positive

V   Zacks Investment Research — November 20, 2025

V gains momentum as Cash App and Afterpay pilot a new pay-over-time debit feature that runs across its network.

image for news Can Visa Gain More Ground as Cash App Flexes Into Pay-Over-Time?

Legendary investor Bill Ackman disclosed no new stock purchases in the third quarter, instead showing a decreased position in shares of Magnificent Seven stock Alphabet Inc (NASDAQ: GOOG)(NASDAQ: GOOGL). With Alphabet hitting new all-time highs since the end of the third quarter, Ackman missed out on millions in potential profits.

image for news Bill Ackman Missed Out On $25 Million Selling Alphabet Shares Early In Q3

BELLEVUE, Wash.--(BUSINESS WIRE)--T-Mobile (NASDAQ: TMUS) today announced a multi-year extension as the Exclusive 5G Partner of the FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX and an expansion to become the Regional 5G Innovation Partner of Formula 1®, underscoring T-Mobile's role as a leading technology and fan experience partner for one of the world's most high-profile sporting organizations. Under the new agreement, T-Mobile will bring 5G-connected technologies supporting broadcast innovations a.

image for news T-Mobile Extends Partnership with FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX, Expands Role as Regional 5G Innovation Partner of Formula 1®

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In WPP To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in WPP between February 27, 2025 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against WPP plc (“WPP” or the “Company”) …

image for news WPP INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of WPP

Sessions with AcariaHealth, the National Association of Specialty Pharmacy (NASP), and Reuters Events deliver actionable insights on biosimilar adoption, patient access, and specialty pharmacy readiness ORLANDO, Fla. , Nov. 20, 2025 /PRNewswire/ -- AcariaHealth, a leading specialty pharmacy and a company of Centene Corporation (NYSE: CNC), announced the completion of three national educational events in October focused on the evolving U.S. biosimilars landscape.

image for news AcariaHealth Highlights National Biosimilars Education Efforts with Three Events

RADNOR, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. (“CarMax”) (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is January 2, 2026.

image for news Class Action Reminder for KMX Investors: Kessler Topaz Meltzer & Check, LLP Reminds CarMax, Inc. (KMX) Investors of Securities Fraud Class Action Lawsuit

Nvidia's Middle East Sales Raise Questions — Negative

NVDA   Bloomberg Technology — November 20, 2025

Bloomberg's Michael Shepard discusses how Washington is reacting to Nvidia's plans to sell chips to the Middle East. He joins Caroline Hyde and Ed Ludlow on “Bloomberg Tech.

image for news Nvidia's Middle East Sales Raise Questions

Quorum Information Technologies Inc. ( QIS:CA ) Q3 2025 Earnings Call November 20, 2025 1:00 PM EST Company Participants Maury Marks - Founder, President, CEO & Director Marilyn Bown - Chief Financial Officer Presentation Operator Good day, and thank you for standing by. Welcome to the Quorum Information Technologies Third Quarter 2025 Results.

image for news Quorum Information Technologies Inc. (QIS:CA) Q3 2025 Earnings Call Prepared Remarks Transcript

Madrigal Pharmaceuticals, Inc. ( MDGL ) Jefferies London Healthcare Conference 2025 November 20, 2025 3:30 AM EST Company Participants William Sibold - CEO, President & Director Mardi Dier - Executive VP & CFO David Soergel - Executive VP & Chief Medical Officer Conference Call Participants Akash Tewari - Jefferies LLC, Research Division Presentation Akash Tewari Jefferies LLC, Research Division Good morning, everyone. We've made it to our last day of our London Healthcare Conference.

image for news Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Jefferies London Healthcare Conference 2025 Transcript